Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
:::

莊茜 (Chien Chuang)

[簡介]

  • 學歷
    國立陽明大學 醫學系 學士
  • 經歷
    現職:
    • - 迄今 臺北榮民總醫院 內科部感染科 主治醫師
    • - 迄今 國立陽明交通大學 醫學系內科學科 兼任講師
    經歷:
    • - 臺北榮民總醫院 契約不分科住院醫師
    • - 臺北榮民總醫院 內科部 住院醫師
    • - 臺北榮民總醫院 內科部感染科 總醫師
    • - 臺中榮民總醫院嘉義暨灣橋分院 感染科 主治醫師
    • - 臺中榮民總醫院嘉義暨灣橋分院 感染管制室 主任
  • 醫療專長
    1. 臨床感染症、微生物學、人類免疫缺乏病毒感染
  • 證照
    中華民國內科專科醫師 中華民國感染症專科醫師
  • 語言專長
    國語、英文、台語

[著作]

近五年代表性著作

1. Su CFChuang C, Lin YT, Chan YJ, Lin JC, Lu PL, Huang CT, Wang JT, Chuang YC, Siu LK, Fung CP. Treatment outcome of non-carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae infections: a multicenter study in Taiwan. Eur J Clin Microbiol Infect Dis. 2018;37(4):651-659. (2021 IF=5.103, Rank 49/136, microbiology) *Chin-Fang Su and Chien Chuang contributed to this manuscript equally.

2. Chuang C, Guo YW, Chen HS. Corrected Sodium Levels for Hyperglycemia is a Better Predictor than Measured Sodium Levels for Clinical Outcomes among Patients with Extreme Hyperglycemia. J Chin Med Assoc. 2020; 83(9):845-851. (2021 IF=3.396, Rank: 71/172, medicine, general & internal)

3. Chuang C, Chou SH, Wang FD, Huang YH, Tsai TH, Lin YT. Fluoroquinolone is an alternative treatment for Klebsiella pneumoniae liver abscess and its impact on length of stay. Int J Antimicrob Agents. 2020;56(4):106120. (2021 IF=15.441, Rank 11/94, infectious diseases)

4. Chuang C, Su CF, Lin JC, Lu PL, Huang CT, Wang JT, Chuang YC, Siu LK, Fung CP, Lin YT. Does Antimicrobial Therapy Affect Mortality of Patients with Carbapenem-Resistant Klebsiella pneumoniae Bacteriuria? A Nationwide Multicenter Study in Taiwan. Microorganisms. 2020; 8(12): 2035. (2021 IF=4.926, Rank 67/157, microbiology)

 

其他著作

1. Chuang C, Fan WC, Lin YT, Wang FD. The emergence of Klebsiella pneumoniae liver abscess in non-diabetic patients and the distribution of capsular types. Gut Pathog. 2016: 8:46 Gut Pathogens. (2021 IF=5.324, Rank 44/136, microbiology)

2. Lin YT, Chuang C, Su CF, Chan YJ, Wang LS, Huang CT, Chuang YC, Siu LK, Fung CP. Efficacy of Appropriate Antimicrobial Therapy on the Survival of Patients With Carbapenem Nonsusceptible Klebsiella Pneumoniae Infection: A Multicenter Study in Taiwan. Medicine. 2015;94(33):e1405. (2021 IF=1.817, Rank: 134/329, medicine, general & internal)

3. Wu PF, Chuang C, Su CF, Lin YT, Chan YJ, Wang FD, Chuang YC, Siu LK, Fung CP. High minimum inhibitory concentration of imipenem as a predictor of fatal outcome in patients with carbapenem non-susceptible Klebsiella pneumoniae. Sci Rep. 2016;6:32665. (2021 IF=4.996, Rank: 19/73, multidisciplinary sciences)

4. Wu PS, Chuang C, Wu PF, Lin YT, Wang FD. Anaerobic coverage as definitive therapy does not affect clinical outcomes in community-onset bacteremic biliary tract infection without anaerobic bacteremia. BMC Infect Dis. 2018;18(1):277. (2021 IF=3.670, Rank 60/94, infectious diseases)

5. Juan CH, Chuang C, Chen CH, Li L, Lin YT. Clinical characteristics, antimicrobial resistance and capsular types of community-acquired, healthcare-associated, and nosocomial Klebsiella pneumoniae bacteremia. Antimicrob Resist Infect Control. 2019 8:1. (2021 IF=6.459, Rank 38/210, Public, Environmental & Occupational Health)

6. Lin YT, Su CF, Chuang C, Lin JC, Lu PL, Huang CT, Wang JT, Chuang YC, Siu LK, Fung CP. Appropriate treatment for bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae and Escherichia coli: A nationwide multicenter study in Taiwan. Open Forum Infect Dis.2018; 6(2):ofy336. (2021 IF=4.423, Rank 61/136, microbiology)

7. Lin YT, Cheng YH, Chuang C, Chou SH, Liu WH, Huang CH, Yang TC, Kreiswirth BN, Chen L. Molecular and Clinical Characterization of Multidrug-Resistant and Hypervirulent Klebsiella pneumoniae Strains from Liver Abscess in Taiwan. Antimicrob Agents Chemother. 2020;64(5) : e00174-20. (2021 IF=5.938, Rank 51/276, pharmacology & pharmacy)

8. Chen KL, Wang SJ, Chuang C, Huang LY, Chiu FY, Wang FD, Lin YT, Chen WM. Novel design for door handle—a potential technology to reduce hand contamination in the COVID-19 pandemic. Am J Med. 2020;133(11):1245-1246 (2021 IF=5.928, Rank: 36/172, medicine, general & internal)

9. Chen PL, Hsiao YH, Chuang C, Feng JY, Ho HL, Lin YT, Chen SJ, Huang SF, Chen HP, Chou TY, Chen YM, Wang FD. The Clinical Manifestations and Interval Changes of Reverse-Transcriptase Quantitative Polymerase Chain Reactions among Different Specimens of Coronavirus Disease 2019 Patients. J Chin Med Assoc. 2021;84(2):151-157. (2021 IF=3.396, Rank: 71/172, medicine, general & internal)

10. Huang PH, Cheng YH, Chen WY, Juan CH, Chou SH, Wang JT, Chuang C, Wang FD, Lin YT. Risk factors and mechanisms of in vivo emergence of colistin resistance in carbapenem-resistant Klebsiella pneumoniae. Int J Antimicrob Agents. 2021;57(6):106342. (2021 IF=15.441, Rank 11/94, infectious diseases)

11. Chen PL, Chuang C, Huang YC, Wu PF, Huang SF, Cheng NC, Lin YT, Chen SJ, Huang LJ, Lee CL, Chen HP, Chan YJ, Wang FD. The epidemiology and etiologies of respiratory tract infection in Northern Taiwan during the early phase of coronavirus disease 2019 (COVID-19) outbreak. J Microbiol Immunol Infect. 2021;54(5):801-807. (2021 IF=10.273, Rank 17/136, microbiology)

回到最上